ap 24

PAP 248–286是一种精液衍生的生物活性肽，也称为前列腺酸性磷酸酶 (248-286) 或PAP (248-286) 肽，属于精液中的精液衍生病毒感染增强子 (SEVI) 因子。该肽能显著增强HIV病毒颗粒与靶细胞间的附着，从而增加HIV感染率。

PAP 248-286 (Prostatic acid phosphatase(248-286)) acetate 是一种生物活性肽，存在于精液中，被识别为精液衍生病毒感染增强子 (SEVI) 因子。此肽可显著增强病毒颗粒与靶细胞的结合，从而增加HIV感染风险。

AP 24149 是一种有效的Src-Abl 双重抑制剂，对Src 和Abl 的IC50值分别为 9.1、3.6 nM[ 1]。

Ponatinib Hydrochloride (AP-24534 Hydrochloride) 是 ponatinib 的盐酸盐。Ponatinib 是一种有效的，具有口服活性的多靶点激酶抑制剂，抑制 Abl，PDGFRα，VEGFR2，FGFR1 和 Src 的 IC50 分别为 0.37 nM、1.1 nM、1.5 nM、2.2 nM 和 5.4 nM。

Ponatinib (AP24534) 是一种有多靶点激酶抑制剂，具有口服活性，可以抑制 Abl、PDGFRα、VEGFR2、FGFR1 和 Src (IC50=0.37 1.1 1.5 2.2 5.4 nM)。Ponatinib 具有抗肿瘤活性，可以用于治疗成人慢性粒细胞白血病。

AP-24226 is a potent dual Src/ ABL kinase inhibitor.

AP-24600 is a bio-active chemical.

AP-24567 is a CYP3A4-mediated metabolite.

AP24163 is an inhibitor of the gatekeeper mutant of BCR-ABL, thereby suppressing in vitro resistance.

FSL-1 TFA, a bacterial-derived toll-like receptor 2 6 (TLR2 6) agonist, enhances resistance to experimental HSV-2 infection[1]. FSL-1 TFA induces MMP-9 production through TLR2 and NF-κB AP-1 signaling pathways in monocytic THP-1 cells[2]. FSL-1 significantly reduces HSV-2 replication in human vaginal epithelial cells (EC)[1].FSL-1 induces significant resistance to experimental genital HSV-2 infection through elaboration of a specific cytokine response profile[1].FSL-1 (50 ng mL, 24 hours) induces MMP-9 expression at both mRNA and protein levels in human monocytic THP-1 cells[2].FSL-1 activates the MAP kinase NF-κB signaling pathway[2]. Cell Viability Assay[1] Cell Line: V11I, V12I or V19I immortalized human vaginal EC FSL-1 application significantly protectes against genital HSV-2 challenge in mice[1]. Animal Model: Female Swiss-Webster mice (weighing 20-25 g)[1] [1]. William A Rose 2nd, et al. FSL-1, a bacterial-derived toll-like receptor 2 6 agonist, enhances resistance to experimental HSV-2 infection. Virol J. 2009 Nov 10;6:195. [2]. Cathryn J Kurkjian,et al. The Toll-Like Receptor 2 6 Agonist, FSL-1 Lipopeptide, Therapeutically Mitigates Acute Radiation Syndrome. Sci Rep. 2017 Dec 11;7(1):17355.